Home Tags HR-positive breast cancer

Tag: HR-positive breast cancer

Datopotamab Deruxtecan Offers Meaningful PFS Benefit in Treatment of HR-positive,...

The positive top-line results from TROPION-Breast01 demonstrate the potential for datopotamab deruxtecan to become an important treatment option for patients with HR-positive, HER2-low or HER2-negative breast cancer in the second-line metastatic setting.